91 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
Sinai.
If we are unable to maintain or enter into agreements with these third parties on acceptable terms, or if any such engagement is terminated
424B5
XENE
Xenon Pharmaceuticals Inc
29 Nov 23
Prospectus supplement for primary offering
5:05pm
terms, or if any such engagement is terminated prematurely, we may be unable to enroll patients on a timely basis or otherwise conduct our trials
424B5
7xgraf8i1 ex9etji7w
23 Jun 22
Prospectus supplement for primary offering
4:09pm
424B5
whuklxa8cks
22 Jun 22
Prospectus supplement for primary offering
4:05pm
8-K
EX-10.1
bxwws0mnos
2 Jun 22
Departure of Directors or Certain Officers
4:03pm
424B5
i3yx 8yz9o3a6w
1 Mar 22
Prospectus supplement for primary offering
5:12pm